Amgen AMGN
NASDAQ AMGN
$465.67 -1.39 (-0.30%)
At close: Nov 13, 2026 · 4:00 PM EST

Amgen (AMGN) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Amgen (AMGN) posted Depreciation & Amortization (CF) of $1.12 billion for Q3 2026, down 14.2% from $1.31 billion a year earlier but up 0.9% from the prior quarter.

Analysis

Amgen (AMGN) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at Amgen was $4.48 billion, down 17.5% year-over-year; for FY2025, it came in at $5.17 billion, down 7.6% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
  • In prior years, Amgen's Depreciation & Amortization (CF) was $5.59 billion in FY2024 (+37.4%), $4.07 billion in FY2023 (+19.1%), $3.42 billion in FY2022 (+0.6%) and $3.4 billion in FY2021 (-5.6%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $828 million in Q2 2022 to a high of $1.4 billion in Q2 2024 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last seven quarters, with an average decline of 10.0% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2024, with growth of 56.3%; the weakest was Q1 2026, with a decline of 19.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $1.11 billion (Q2 2026), $1.12 billion (Q1 2026) and $1.13 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.12 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 192.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.58 Bn
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn 69.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.12 Bn
Jun 30, 2026 1.11 Bn
Mar 31, 2026 1.12 Bn
Dec 31, 2025 1.13 Bn
Sep 30, 2025 1.31 Bn
Jun 30, 2025 1.34 Bn
Mar 31, 2025 1.39 Bn
Dec 31, 2024 1.40 Bn
Sep 30, 2024 1.40 Bn
Jun 30, 2024 1.40 Bn
Mar 31, 2024 1.40 Bn
Dec 31, 2023 1.38 Bn
Sep 30, 2023 895.00 Mn
Jun 30, 2023 896.00 Mn
Mar 31, 2023 900.00 Mn
Dec 31, 2022 911.00 Mn
Sep 30, 2022 837.00 Mn
Jun 30, 2022 828.00 Mn
Mar 31, 2022 841.00 Mn
Dec 31, 2021 852.00 Mn
API Access

Amgen Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AMGN&period=max&api_key=YOUR_API_KEY